Journal
PLANT CELL REPORTS
Volume 39, Issue 9, Pages 1109-1114Publisher
SPRINGER
DOI: 10.1007/s00299-020-02560-w
Keywords
SARS-CoV-2; Plant-based drugs; Antiviral biomolecules; Plant-based vaccines; Traditional medicine; Synergistic effect
Categories
Funding
- J.C. Bose National Fellowship Grant of Department of Science and Technology, Government of India [JCB/2018/000001]
- Council for Scientific and Industrial Research
Ask authors/readers for more resources
The exponential spread of Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emphasizes the immediate need for effective antiviral drugs and vaccines that could control and prevent the spread of this pandemic. Several new and repurposed drugs are being tested for their effectiveness in the treatment regime, and the development of vaccines is underway. The availability of genome sequence information of the virus and the identification of potential targets to neutralize and eradicate the infection have enabled the search for novel as well as existing molecules to perform the desired function. However, the application of plants in the development of potential biomolecules, such as antibiotics and vaccines, is limited. Traditional medicines involving plant-based formulations have proven successful in boosting immunity and providing tolerance to virus infections. Still, in-depth studies are not available to explore the bioactive compounds of plant origin and their mechanism of action. Given this, the current opinion article conveys our thoughts and perspectives on the promising usage of plant-based biomolecules in circumventing SARS-CoV-2, and how these molecules can work synergistically with other potential drugs for treating SARS-CoV-2.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available